Lakefront Biotherapeutics | GLPG - PE Price to Earnings


Lakefront Biotherapeutics reported 2.54 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
argenx SE 32.12 10.9 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
Biogen 13.7 0.32 Mar/2026
Genmab 17.14 4.39 Dec/2025
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
GRIFOLS 10.98 5.83 Mar/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Incyte 15.35 0.51 Mar/2026
Merck 12.74 7.82 Mar/2026
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novartis 20.17 2.32 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.84 0.14 Mar/2026
UCB 29.7 5.52 Dec/2025
Vertex Pharmaceuticals 25.82 0.33 Mar/2026